Skip to main content

People in the News: Matthias Mann; Laura Lauman; and More

Premium

The German Research Foundation this week named Matthias Mann one of eleven winners of the 2012 Leibniz Prize for his work in the development of mass spec-based proteomics.

A director at the Max Planck Institute of Biochemistry in Martinsried, Mann is the developer of a number of widely used proteomics techniques and platforms, including the SILAC protein labeling method and the MaxQuant bioinformatics software. One of the Germany’s most prestigious scientific awards, the Leibniz Prize comes with €2.5 million ($3.3 million) in cash. The awards ceremony will be held on Feb. 27, 2012, in Berlin.


Harvey Millar this week received the Australian Academy of Science’s 2012 Fenner Medal in recognition of his work in plant proteomics.

Millar is a chief investigator at the ARC Centre of Excellence in Plant Energy Biology at the University of Western Australia and the director of the UWA Center for Comparative Analysis of Biomolecular Networks. His research focuses on plant respiration, energy production, and response to environmental stress.

The Fenner Medal is given each year to a scientist under 40.


Illumina announced this week that it has appointed Laura Lauman vice president of marketing.

Previously, Lauman was president of AB Sciex. Before that she was general manager of Life Technologies/Applied Biosystems’ Proteomics and Small Molecule division.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.